Tracking the COVID-19 vaccines: The global landscape
ABSTRACT COVID-19, a respiratory infectious disease, occurs due to Severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2). Millions of individuals around the world …
respiratory syndrome coronavirus-2 (SARS-CoV-2). Millions of individuals around the world …
Waning immunity and IgG4 responses following bivalent mRNA boosting
Messenger RNA (mRNA) vaccines were highly effective against the ancestral SARS-CoV-2
strain, but the efficacy of bivalent mRNA boosters against XBB variants was substantially …
strain, but the efficacy of bivalent mRNA boosters against XBB variants was substantially …
Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination
Group 2B β-coronaviruses (sarbecoviruses) have caused regional and global epidemics in
modern history. Here, we evaluate the mechanisms of cross-sarbecovirus protective …
modern history. Here, we evaluate the mechanisms of cross-sarbecovirus protective …
Predictors of long-term neutralizing antibody titers following COVID-19 vaccination by three vaccine types: the BOOST study
AA Prather, EG Dutcher, J Robinson, J Lin… - Scientific reports, 2023 - nature.com
As concerns related to the COVID-19 pandemic continue, it is critical to understand the
impact of vaccination type on neutralizing antibody response durability as well as to identify …
impact of vaccination type on neutralizing antibody response durability as well as to identify …
Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies
Rapid and accurate measurement of the severe acute respiratory syndrome coronavirus 2
(SARS-CoV2)-specific neutralizing antibodies (nAbs) is paramount for monitoring immunity …
(SARS-CoV2)-specific neutralizing antibodies (nAbs) is paramount for monitoring immunity …
Immunoglobulins response of COVID-19 patients, COVID-19 vaccine recipients, and random individuals
Background The development of specific immunoglobulins to COVID-19 after natural
infection or vaccination has been proposed. The efficacy and dynamics of this response are …
infection or vaccination has been proposed. The efficacy and dynamics of this response are …
Long-term systemic and mucosal SARS-CoV-2 IgA response and its association with persistent smell and taste disorders
Introduction Current approved COVID-19 vaccines, notably mRNA and adenoviral vectored
technologies, still fail to fully protect against infection and transmission of various SARS-CoV …
technologies, still fail to fully protect against infection and transmission of various SARS-CoV …
Enhanced antibody responses in fully vaccinated individuals against pan-SARS-CoV-2 variants following Omicron breakthrough infection
Omicron has become the globally dominant severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) variant, creating additional challenges due to its ability to evade …
2 (SARS-CoV-2) variant, creating additional challenges due to its ability to evade …
The serological sciences network (SeroNet) for COVID-19: depth and breadth of serology assays and plans for assay harmonization
ABSTRACT In October 2020, the National Cancer Institute (NCI) Serological Sciences
Network (SeroNet) was established to study the immune response to COVID-19, and “to …
Network (SeroNet) was established to study the immune response to COVID-19, and “to …
COVID-19 vaccination responses with different vaccine platforms in patients with inborn errors of immunity
L Erra, I Uriarte, A Colado, MV Paolini… - Journal of Clinical …, 2023 - Springer
Patients with inborn errors of immunity (IEI) in Argentina were encouraged to receive
licensed Sputnik, AstraZeneca, Sinopharm, Moderna, and Pfizer vaccines, even though …
licensed Sputnik, AstraZeneca, Sinopharm, Moderna, and Pfizer vaccines, even though …